Antimicrobial resistance is a major public health issue worldwide, largely driven by antibiotic misuse and overuse. Impacting both people and animals, coordinated action to combat resistance is required in both human and veterinary medicine.
The emergence and spread of multi-drug resistant organisms (MDROs) is facilitated by increasing international trade and travel, growing human and animal populations, and the widespread use of broad-spectrum antibiotics.
Today, there are few antibiotics in the development pipeline to meet the challenge of multi-drug resistance. The most prudent use of existing antibiotics in both humans and animals is therefore essential to preserve their therapeutic efficacy and prevent the further emergence and spread of multi-drug resistant bacteria.
The Microbiology Pathway depicts bioMérieux’s complete approach to improving efficiencies and enhancing technology for microbiology labs of all sizes. A key component of The Microbiology Pathway is a comprehensive microbial Identification and Antibiotic Susceptibility Testing (ID/AST) system that stores, interprets, and reports test results with unparalleled speed, precision, and accuracy.
bioMérieux provides a full range of solutions for: